Literature DB >> 26596784

Detecting hepatocellular carcinoma in blood.

Lulu Hu1,2, Chuan He1,2.   

Abstract

Liquid biopsy is ideal for early diagnosis of cancer and for prognosis upon treatment. Wen et al. describe a methylated CpG tandems amplification and sequencing method to profile hypermethylated CpG islands genome-widely in cell-free DNA, and further identify high performance markers in blood for potential detection of early stage hepatocellular carcinoma.

Entities:  

Mesh：

Year:  2015        PMID： 26596784      PMCID： PMC4670993          DOI： 10.1038/cr.2015.136

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   25.617


  8 in total

Review 1.  Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma.

Authors:  Igor P Pogribny; Ivan Rusyn
Journal:  Cancer Lett       Date:  2012-02-02       Impact factor: 8.679

2.  DNA methylation biomarkers for blood-based colorectal cancer screening.

Authors:  Catherine Lofton-Day; Fabian Model; Theo Devos; Reimo Tetzner; Juergen Distler; Matthias Schuster; Xiaoling Song; Ralf Lesche; Volker Liebenberg; Matthias Ebert; Bela Molnar; Robert Grützmann; Christian Pilarsky; Andrew Sledziewski
Journal:  Clin Chem       Date:  2007-12-18       Impact factor: 8.327

3.  Medicine. Keeping tabs on tumor DNA.

Authors:  Jocelyn Kaiser
Journal:  Science       Date:  2010-02-26       Impact factor: 47.728

Review 4.  Cell-free nucleic acids as biomarkers in cancer patients.

Authors:  Heidi Schwarzenbach; Dave S B Hoon; Klaus Pantel
Journal:  Nat Rev Cancer       Date:  2011-05-12       Impact factor: 60.716

5.  Detection of circulating tumor DNA in early- and late-stage human malignancies.

Authors:  Chetan Bettegowda; Mark Sausen; Rebecca J Leary; Isaac Kinde; Yuxuan Wang; Nishant Agrawal; Bjarne R Bartlett; Hao Wang; Brandon Luber; Rhoda M Alani; Emmanuel S Antonarakis; Nilofer S Azad; Alberto Bardelli; Henry Brem; John L Cameron; Clarence C Lee; Leslie A Fecher; Gary L Gallia; Peter Gibbs; Dung Le; Robert L Giuntoli; Michael Goggins; Michael D Hogarty; Matthias Holdhoff; Seung-Mo Hong; Yuchen Jiao; Hartmut H Juhl; Jenny J Kim; Giulia Siravegna; Daniel A Laheru; Calogero Lauricella; Michael Lim; Evan J Lipson; Suely Kazue Nagahashi Marie; George J Netto; Kelly S Oliner; Alessandro Olivi; Louise Olsson; Gregory J Riggins; Andrea Sartore-Bianchi; Kerstin Schmidt; le-Ming Shih; Sueli Mieko Oba-Shinjo; Salvatore Siena; Dan Theodorescu; Jeanne Tie; Timothy T Harkins; Silvio Veronese; Tian-Li Wang; Jon D Weingart; Christopher L Wolfgang; Laura D Wood; Dongmei Xing; Ralph H Hruban; Jian Wu; Peter J Allen; C Max Schmidt; Michael A Choti; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos; Luis A Diaz
Journal:  Sci Transl Med       Date:  2014-02-19       Impact factor: 17.956

6.  Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia.

Authors:  V Vasioukhin; P Anker; P Maurice; J Lyautey; C Lederrey; M Stroun
Journal:  Br J Haematol       Date:  1994-04       Impact factor: 6.998

7.  Soluble normal and mutated DNA sequences from single-copy genes in human blood.

Authors:  G D Sorenson; D M Pribish; F H Valone; V A Memoli; D J Bzik; S L Yao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1994 Jan-Feb       Impact factor: 4.254

8.  Genome-scale detection of hypermethylated CpG islands in circulating cell-free DNA of hepatocellular carcinoma patients.

Authors:  Lu Wen; Jingyi Li; Huahu Guo; Xiaomeng Liu; Shengmin Zheng; Dafang Zhang; Weihua Zhu; Jianhui Qu; Limin Guo; Dexiao Du; Xiao Jin; Yuhao Zhang; Yun Gao; Jie Shen; Hao Ge; Fuchou Tang; Yanyi Huang; Jirun Peng
Journal:  Cell Res       Date:  2015-10-30       Impact factor: 25.617
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.